Skip to main content
Clinical Trials/NCT00568217
NCT00568217
Completed
Phase 4

Antipyretics for Preventing Recurrences of Febrile Seizures

University of Oulu1 site in 1 country231 target enrollmentSeptember 1997

Overview

Phase
Phase 4
Intervention
Diclofenac, Paracetamol, Ibuprofen
Conditions
Recurrence of Febrile Seizure
Sponsor
University of Oulu
Enrollment
231
Locations
1
Primary Endpoint
recurrence of febrile seizure
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

We wanted to find out if the early use of antipyretics is capable in preventing recurrences of febrile seizures. When a child has had his/her first febrile seizure, the parents were instructed to give him/her antipyretic medication every time when the child had a new episode of fever during two years.

Registry
clinicaltrials.gov
Start Date
September 1997
End Date
August 2005
Last Updated
18 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • First febrile convulsion

Exclusion Criteria

  • Any prior convulsion or antiepileptic medication

Arms & Interventions

1 drug

diclofenac 15 mg/kg suppository once

Intervention: Diclofenac, Paracetamol, Ibuprofen

2 drug

Placebo suppository once

Intervention: Diclofenac, Paracetamol, Ibuprofen

3 drug

acetaminophen mixture 15 mg/kg up to four times a day

Intervention: Diclofenac, Paracetamol, Ibuprofen

4 drug

ibuprofen mixture 10 mg/kg up to four times a day

Intervention: Diclofenac, Paracetamol, Ibuprofen

5 drug

oral placebo mixture up to four times a day

Intervention: Diclofenac, Paracetamol, Ibuprofen

Outcomes

Primary Outcomes

recurrence of febrile seizure

Time Frame: two years

Secondary Outcomes

  • we only had the primary outcome measure(two years)

Study Sites (1)

Loading locations...

Similar Trials